1692 Investors following Venus Remedies. Share this News with them.
0
Like this story, share it with millions of investors on M3
Venus Remedies gets patent for Vancoplus in Japan
Venus Remedies has got patent for research product Vancoplus in Japan. It will outlicense Vancoplus product to major pharma players, reports CNBC-TV18.
Venus Remedies has got patent for research product Vancoplus in Japan. It will outlicense Vancoplus product to major pharma players, reports CNBC-TV18.
Venus Remedies touched an intraday high of Rs 196.90 and an intraday low of Rs 173.35. At 11:33 hrs the share was quoting at Rs 193.30, up Rs 19.80, or 11.41%.
It was trading with volumes of 70,751 shares, compared to its 5-day average of 5,061 shares, an increase of 1,297.85%.
In the previous trading session, the share closed up 2.03% or Rs 3.45 at Rs 173.50.
